2.16
-0.04 (-1.82%)
-0.04 (-1.82%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aclaris Therapeutics Inc | ACRS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.04 | -1.82% | 2.16 | 2.05 | 2.2231 | 2.161 | 2.20 | 16:30:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.17 | 2.18 | 0.01 | 0.46% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,902 | 416,846 | $ 2.11 | $ 879,809 | 882,261 | 0.70 - 4.99 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:27:59 | formt | 1,000 | $ 2.17 | USD |
Aclaris Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 90.43M | 41.87M | 39.82M | $ 12.98M | $ - | -3.90 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Aclaris Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACRS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.15 | 2.70 | 1.82 | 2.20 | 913,857 | 0.01 | 0.47% |
| 1 Month | 2.03 | 3.34 | 1.82 | 2.29 | 971,340 | 0.13 | 6.4% |
| 3 Months | 1.29 | 4.99 | 1.20 | 1.91 | 815,664 | 0.87 | 67.44% |
| 6 Months | 1.38 | 4.99 | 0.70 | 1.66 | 571,003 | 0.78 | 56.52% |
| 1 Year | 0.85 | 4.99 | 0.70 | 1.57 | 920,350 | 1.31 | 154.12% |
| 3 Years | 25.30 | 28.93 | 0.70 | 6.38 | 593,733 | -23.14 | -91.46% |
| 5 Years | 11.94 | 33.88 | 0.70 | 8.96 | 425,406 | -9.78 | -81.91% |
Aclaris Therapeutics Description
| Aclaris Therapeutics Inc is a clinical-stage specialty pharmaceutical company which operates in United States. It focuses on identifying, developing and commercializing differentiated drugs to address significant unmet needs in dermatology. The company holds a drug candidate, A-101 Topical Solution which is a proprietary high-concentration hydrogen peroxide topical solution which is being developed as a prescription treatment for seborrheic keratosis (SK) a common non-malignant skin tumor. Its pipeline of drug candidates includes A-101 as a Topical Solution for treatment of SK, common warts; A-102 as a gel dosage form for treatment of SK and warts and A-201 and A-301 as an oral and topical formulation for treatment of autoimmune dermatologic respectively. |
